![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2013
Müller, Olaf; Mockenhaupt, F. P.; Marks, B.; Meissner, P.; Coulibaly, B.; Kuhnert, R.; Buchner, Hannes; Schirmer, Heiner; Walter-Sack, Ingeborg; Sie, A. und Mansmann, Ulrich
(2013):
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
In: Pharmacoepidemiology and Drug Safety, Bd. 22, Nr. 4: S. 376-385
2012
Müller, Olaf; Meissner, P. und Mansmann, Ulrich
(2012):
Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.
In: Drug Safety, Bd. 35, Nr. 1: S. 85
2010
Bountogo, M.; Zoungrana, Augustin; Coulibaly, B.; Klose, C.; Mansmann, Ulrich; Mockenhaupt, F. P.; Burhenne, Jürgen; Mikus, Gerd; Walter-Sack, Ingeborg; Schirmer, Heiner; Sie, A.; Meissner, P. und Müller, Olaf
(2010):
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
In: Tropical Medicine and International Health, Bd. 15, Nr. 6: S. 713-717
2005
Mandi, Germain; Witte, Steffen; Meissner, P.; Coulibaly, B.; Mansmann, Ulrich; Rengelshausen, J.; Schiek, W.; Jahn, A.; Sanon, M.; Wust, K.; Walter-Sack, Ingeborg; Mikus, Gerd; Burhenne, Jürgen; Riedel, K. D.; Schirmer, Heiner; Kouyaté, Bocar und Müller, Olaf
(2005):
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
In: Tropical Medicine and International Health, Bd. 10, Nr. 1: S. 32-38